Carson Wealth (CWM LLC)’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-310
Closed – – 4385
2022
Q3
$0 Hold
310
– – ﹤0.01% 4307
2022
Q2
$1K Sell
310
-1,167
-79% -$1.72K ﹤0.01% 3728
2022
Q1
$3K Buy
1,477
+1,167
+376% +$2.29K ﹤0.01% 3112
2021
Q4
$1K Buy
+310
New +$1.15K ﹤0.01% 3448
2016
Q1
– Sell
-310
Closed -$11K – 825
2015
Q4
$11K Buy
+310
New +$20K ﹤0.01% 459

Other funds holding CLVS

Carson Wealth (CWM LLC)'s CLVS Position: Q4 2022 in Review

Carson Wealth (CWM LLC) sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 310 shares.

Carson Wealth (CWM LLC) first reported a position in CLVS in Q4 2015 and held it in 5 quarters. The position peaked at $11K in Q4 2015. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Carson Wealth (CWM LLC) reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 310 Clovis Oncology, Inc. shares in Q4 2022.
  • Carson Wealth (CWM LLC) first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 5 quarters.
  • Carson Wealth (CWM LLC)'s Clovis Oncology, Inc. position peaked at $11K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2022, filed 1 Feb 2023.